The Berlin-based start-up Better@Home, founded in the summer of 2018 and operating in Germany, successfully completed its first financing round in December with more than 1 million euros. The investors are CompuGroup Medical Research GmbH, an undisclosed healthcare consultant, and B.I.F. GmbH, the holding company of Hamburg-based business angel Wolfgang Biedermann.

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines. In September, the Trust set out a highly ambitious goal to remove the majority of its 350 fax machines by the beginning of 2019 in order to streamline workflows and productivity, improve security and improve the timeliness of patient care.

Enovacom and Stalis have joined forces to help UK health and care providers breakdown the technical barriers of extracting and sharing patient data to create integrated care records that support better care outcomes and improvements in the patient experience.

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment, spending on the right systems at the right level, and empowerment emerged as key themes.

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates to the formation of 'crypto-objects', a novel security procedure linking Artificial Intelligence (AI) and blockchain technology.

The study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany.

BIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK's CRT-DX technology provides therapy through two ventricular leads and features a floating dipole for complete atrial diagnostics without an additional lead.